The Department of Justice announced a strategic realignment of white-collar crime enforcement, introducing a new framework with 10 targeted priority areas. While not a complete reduction, the policy involves resource constraints, shifting investigative focus, and implementing more efficient …
Donald TrumpTrump AdministrationMatthew GaleottiJames McHenry IIIcryptocorruptionforeign-influencejustice-weaponizationcorporate-crime+4 more
McKinsey & Company agrees to pay $650 million to settle federal criminal and civil investigations into its role in helping Purdue Pharma ’turbocharge’ sales of OxyContin, the highly addictive opioid painkiller at the center of America’s overdose epidemic. This marks the first …
McKinsey & CompanyU.S. Department of JusticePurdue PharmaMartin EllingFood and Drug Administration (FDA)mckinseyopioid-crisispurdue-pharmaconsulting-scandalcorporate-crime+4 more
McKinsey Africa enters into a three-year deferred prosecution agreement with the U.S. Department of Justice, agreeing to pay more than $122 million (approximately R2.2 billion) to resolve criminal charges for conspiracy to violate the anti-bribery provisions of the Foreign Corrupt Practices Act. The …
McKinsey AfricaU.S. Department of JusticeVikas SagarSouth African National Prosecuting AuthorityTransnet+1 moremckinseysouth-africastate-capturebriberycorruption+5 more
The Department of Justice notified Boeing and the federal court that Boeing breached its January 2021 deferred prosecution agreement by failing to maintain the required compliance and ethics program. The finding came after the January 5, 2024 Alaska Airlines door plug blowout revealed that Boeing …
Department of JusticeBoeingFederal District CourtCriminal Division Fraud Section346 crash victims' familiesboeingdojdeferred-prosecutionalaska-airlinesdoor-plug+2 more
A Manhattan jury convicted the Trump Organization on all 17 criminal counts of tax fraud and falsifying business records after deliberating for approximately one day, marking the first time Donald Trump’s company faced criminal charges, trial, and conviction. The jury found two …
In December 2021, researchers at Harvard Medical School published a landmark study in Annals of Internal Medicine demonstrating that hospitals acquired by private equity firms experienced significant increases in emergency department mortality—7 additional deaths per 10,000 visits (approximately 10% …
On October 21, 2020, the Department of Justice announced a settlement totaling more than $8 billion with Purdue Pharma—touted as the largest penalties ever levied against a pharmaceutical manufacturer—yet the settlement allowed the Sackler family to keep the vast majority of billions extracted from …
U.S. Department of JusticePurdue PharmaSackler FamilyRichard SacklerDavid Sackler+4 moreopioid-crisiscorporate-crimeaccountability-failuredeferred-prosecutionwealth-extraction
Boeing’s Board of Directors fired CEO Dennis Muilenburg on December 23, 2019, over his handling of the 737 MAX crisis that killed 346 people in two crashes. Despite presiding over the deadliest corporate safety scandal in aviation history, Muilenburg departed with approximately $62 million in …
Dennis MuilenburgBoeing Board of DirectorsDavid Calhoun346 crash victimsVictims' familiesboeingexecutive-compensationimpunity737-maxcorporate-crime+1 more
On September 15, 2019, Purdue Pharma filed for Chapter 11 bankruptcy protection after facing thousands of lawsuits from states, local governments, Native American tribes, and victims related to the opioid crisis. The bankruptcy filing was a strategic maneuver designed to shield the billionaire …
In January 2017, diabetes patients filed a federal antitrust class action lawsuit alleging that the three pharmaceutical manufacturers controlling 99% of the U.S. insulin market—Eli Lilly, Novo Nordisk, and Sanofi—conspired to raise insulin prices in near-lockstep coordination, increasing prices by …
Eli LillyNovo NordiskSanofiCVS CaremarkExpress Scripts+1 morehealthcarepharmaceutical-price-gougingantitrustcorporate-crimeregulatory-capture
In August 2016, Mylan CEO Heather Bresch faced intense scrutiny when it was revealed that EpiPen prices had increased from approximately $103 in 2007 to over $608 by 2016—a nearly 550% price increase for a life-saving allergy treatment. The scandal exposed pharmaceutical price gouging, the failure …
In September 2015, Turing Pharmaceuticals under CEO Martin Shkreli purchased the American marketing rights to Daraprim (pyrimethamine) and immediately raised the price from $13.50 to $750 per pill—a price increase of over 5,000%. The move became a symbol of pharmaceutical price gouging and exposed …
Martin ShkreliTuring Pharmaceuticalshealthcarepharmaceutical-price-gougingcorporate-crimeregulatory-capture
During a critical congressional testimony before the Senate Judiciary Committee on March 6, 2013, Attorney General Eric Holder revealed the Department of Justice’s emerging doctrine of ’too big to jail’, acknowledging that prosecuting certain financial institutions could …
Eric HolderDepartment of JusticeJPMorgan ChaseBank of AmericaCitigroup+2 moreinstitutional-captureregulatory-capturecorruptionfinancial-crisisbank-prosecution+3 more
On May 10, 2007, Purdue Pharma pleaded guilty to a felony charge of illegally misbranding OxyContin in an effort to mislead and defraud physicians and agreed to pay $600 million—representing approximately 90 percent of OxyContin profits during the offense period. The company admitted to misleading …
Purdue PharmaMichael FriedmanHoward R. UdellPaul D. GoldenheimU.S. Department of Justiceopioid-crisiscorporate-crimeaccountability-failuredeferred-prosecutionregulatory-capture+1 more
The Department of Justice announced that HCA Inc. (formerly Columbia/HCA), once led by Rick Scott, agreed to pay the United States $631 million in civil penalties and damages, bringing the total recovery to $1.7 billion when combined with earlier settlements—the largest healthcare fraud case in U.S. …
HCA HealthcareRick ScottDepartment of Justicehealthcaremedicare-fraudhospitalrick scottregulatory-capture+1 more
Purdue Pharma’s lucrative bonus system paid sales representatives an average of $71,500 in annual bonuses—more than their $55,000 base salary—with bonuses ranging from $15,000 to nearly $240,000. In 2001 alone, Purdue paid $40 million in sales incentive bonuses, systematically incentivizing …
Charles H. Keating Jr. was indicted on 42 counts of fraud and racketeering related to the Lincoln Savings and Loan collapse. The indictment exposed massive financial fraud involving risky junk bond investments that led to billions in losses for investors and taxpayers.
Charles H. Keating Jr.Charles Keating IIIfinancial-fraudsavings-and-loan-crisiscorporate-crimeracketeeringwhite-collar-crime
Charles H. Keating Jr.’s Lincoln Savings and Loan Association in Irvine, California, was discovered to have $135 million in unreported losses and substantially exceeded risky investment limits. The bank was selling high-risk, uninsured junk bonds to 22,000 unsuspecting investors, many of whom …
Charles H. Keating Jr.Lincoln Savings and Loan Associationfinancial-fraudsavings-and-loan-crisiscorporate-crimeinvestment-fraudwhite-collar-crime
On September 3, 1973, a fire destroys the baghouse pollution control system at the Bunker Hill lead smelter in Kellogg, Idaho—then the largest smelting facility in the world. In a secret board meeting, Gulf Resources & Chemical Corp., the facility’s owner, makes a calculated decision to …
Gulf Resources & Chemical Corp.Bunker Hill Mining & Metallurgical ComplexIdaho Department of HealthU.S. Environmental Protection Agencycorporate-crimeenvironmental-destructionmining-industrypublic-healthcorporate-negligence